2022-08-24 PRESSRELEASE Arcoma receives order of 8 systems to Thailand Arcoma AB has received an order of 8 X-ray systems…
LONDON and RALEIGH, N.C., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”),…
COPENHAGEN, Denmark, August 24, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress…
PRESS RELEASE: 24 August 2022, 07:00 CEST Biocartis Obtains ISO 27001 Certification for Information Security Management Mechelen, Belgium, 24 August 2022 –…
Public Health AlertWASHINGTON, Aug. 23, 2022 (GLOBE NEWSWIRE) -- The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS)…
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Aug. 23, 2022…
PORTLAND, Ore., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) (the “Company” or “Chalice Brands”),…
VANCOUVER, British Columbia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader…
Abivertinib is a novel third-generation epidermal growth factor receptor (EGFR) inhibitor that irreversibly targets mutant forms of EGFR in advanced…
This partnership brings eSight 4 availability to 1,298 VA centers nationwideTORONTO, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Leading vision-enhancement platform,…